期刊
INTERNATIONAL IMMUNOPHARMACOLOGY
卷 49, 期 -, 页码 222-230出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.intimp.2017.05.039
关键词
Glucocorticoids; NLRP-1 inflanunasome; Neuroinflammation; Neurodegeneration; Alzheimer's disease
资金
- National Natural Science Foundation of China [81371329, 81671384]
- Natural Science Foundation of Anhui Province Education Department [KJ2015A298, KJ2016A357]
Neuroinflammation mediated by NLRP-1 inflammasome plays an important role in the pathogenesis of neuro-degeneration diseases such as Alzheimer's disease (AD). Chronic glucocorticoids (GCs) exposure has deleterious effect on the structure and function of neurons and was found to be correlated with development and progression of AD. We hypothesize that chronic glucocorticoids may down-regulate the expression of glucocorticoids receptor (GR) and activate NLRP-1 inflammasome in hippocampal neurons, which may promote neuro-inflammation and induce neuronal injury. The present results showed that chronic DEX exposure significantly increased LDH release and apoptosis, decreased MAP2 and GR expression in hippocampal neurons. DEX (5 mu M) exposure for 3 d significantly increased the expression of NLRP-1, ASC, caspase-1 and IL-1 beta in the hippocampal neurons and the release of IL-1 beta and IL-18 in the supernatants. Moreover, DEX (1, 5 mu M) treatment for 3 d significantly increased the expression of NF-kappa B in hippocampal neurons. The GR antagonist, mifepristone (RU486), had protective effects on chronic DEX induced hippocampal neurons injury and NLRP1 inflammasome activation. The results suggest that chronic GCs exposure can decrease GR expression and increase neuro-inflammation via NLRP1 inflammasome and promote hippocampal neurons degeneration, which may play an important role in the progression and development of AD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据